While activation of Notch1 is able per se to suppress NET tumor growth and is associated with reduction of NET tumor markers [90, 91], SSTR2 up-regulation has been used to synergistically increase the cytotoxicity of a SSTR-targeting camptothecin-somatostatin conjugate [92]. The gene discussed is NOTCH1; the disease is neoplasm.